Delivery Order SPE2DB20D1051-SPE2DB25FD7WB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Cream in a 60-gram unit, with a contract ceiling value of $1,088.04. This firm fixed price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 7, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same city....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,548.75 for ZORYVE 0.3% Cream (60GM) on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract supporting federal medical procurement needs. The award is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Cream in a 60-gram quantity, with a contract ceiling value of $2,100.10. This competitively awarded, firm fixed-price delivery order was issued on August 6, 2025, with an ultimate completion date of August 7, 2025. The contract utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitive delivery order award from the Defense Logistics Agency on April 29, 2025, for ZORYVE 0.3% Cream in a 60-gram quantity. This firm fixed-price delivery order, valued at $5,656.30 and due for completion by April 30, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,246.51 to AmerisourceBergen Drug Corp for ZORYVE 0.15% Cream 60GM, a topical pharmaceutical product. This competitively awarded, firm fixed-price delivery order was issued on July 16, 2025, with an ultimate completion date of July 17, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 28, 2025, for ZORYVE 0.15% Cream in a 60-gram size. This firm fixed-price delivery order, valued at $1,018.11, represents a competitive award with no set-aside designation and carries an ultimate completion date of July 29, 2025. The contract is executed under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Cream 60GM with a ceiling value of $7,270.70. This contract was competitively awarded with no set-aside designation and utilizes firm fixed pricing, with a delivery deadline of July 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,582.11 by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of ZORYVE 0.15% Cream in 60-gram quantities. This is a firm fixed-price contract with an ultimate completion date of August 1, 2025, and no set-aside designation was used in the award. The contract will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,345.15 firm fixed-price contract is for the supply of the medication "ZORYVE 0.3% CREAM 60GM" and has an ultimate completion date of December 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,149.04, is a delivery order for the medication "ZORYVE 0.3% CREAM 60GM" with an ultimate completion date of April 30, 2025. The contract is not set-aside and was awarded on a firm fixed-price basis. Amerisourcebergen Drug Corp is the prime contractor and holds a larger...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB25FD7WBDelivery Order
The Defense Logistics Agency awarded a $1,036.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of ZORYVE 0.3% Cream in 60-gram units. This is a non-set-aside contract with an ultimate completion date of April 25, 2025, and performance occurring at the vendor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a wide range of pharmaceutical products and medical commodities to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor particularly for military and veteran healthcare systems. The company has demonstrated capability to meet federal procurement requirements through open competition, with its contract awards encompassing specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order represents one of numerous competitively awarded, firm fixed-price transactions the company executes through its DLA master contract, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 4/24/25 |